PillRx only · Tablet, Delayed Release · Oral
Naproxen
Naproxen
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers9 labelers
Packages25
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.034
Latest avg · Jun 17, 2026
+10%
Since Dec 17, 2025
9
Active US suppliers
44%
Top-2 supplier share*
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Proficient Rx LP | unknown | 8 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 3 | SUPPLYING |
| Cipla USA Inc. | unknown | 3 | SUPPLYING |
| SUNRISE PHARMACEUTICAL, INC | unknown | 2 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| TRUPHARMA, LLC | unknown | 2 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Zameer Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.